Related Experiment Video
Updated: May 10, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Novel autoantigens in type 1 diabetes
Shuhong Han1, William Donelan, Hai Wang
1Department of Medicine, University of Florida College of Medicine Gainesville, Florida 32610, USA.
American Journal of Translational Research
|June 1, 2013
Summary
Type 1 diabetes (T1DM) involves immune responses to beta cell autoantigens (AAgs). This study highlights recently discovered AAgs, offering new insights into T1DM pathogenesis and potential clinical applications.
Area of Science:
- Immunology
- Endocrinology
- Autoimmunity
Background:
- Type 1 diabetes mellitus (T1DM) is an autoimmune disease targeting pancreatic beta cells.
- Beta cell proteins recognized as autoantigens (AAgs) trigger immune responses, leading to T1DM.
- Existing research extensively covers well-characterized T1DM autoantigens.
Purpose of the Study:
- To review recently identified autoantigens associated with Type 1 diabetes.
- To discuss the clinical relevance of novel T1DM autoantigens.
- To provide updated insights into T1DM pathogenesis.
Main Methods:
- Literature review focusing on recent discoveries in T1DM autoantigens.
- Analysis of the characteristics and clinical implications of selected AAgs.
- Synthesis of current knowledge on T1DM autoantigen identification.
Main Results:
- The list of beta cell-specific autoantigens in T1DM is expanding.
- Recently identified AAgs include PDX1, ZnT8, CHGA, and IAAP.
- These AAgs are crucial for understanding T1DM development and progression.
Conclusions:
- Newly discovered autoantigens offer valuable tools for T1DM prediction and diagnosis.
- Further research into these AAgs can advance antigen-specific immunotherapy.
- Understanding T1DM autoantigens is key to unraveling disease mechanisms.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...